Posted by Michael Wonder on 03 Jul 2024
Kye Pharmaceuticals announces the availability of Quillivant ER chewable tablets for the treatment of children with ADHD
2 July 2024 - Quillivant ER chewable tablets are the first and only extended release chewable methylphenidate tablets approved in Canada.
Kye Pharmaceuticals announced today that Quillivant ER chewable tablets (methylphenidate hydrochloride extended-release chewable tablets) are now available in Canada.
